Search research articles
Contact Us
Filters
Showing results (191-200 of 194) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 194 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 1997
Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia
T van der Poll, P M Jansen, W J Montegut, et al.
The Journal of Experimental Medicine
|
July 1, 1996
A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon
M B Welborn, K Van Zee, P D Edwards, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1996
Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081
K J Van Zee, L L Moldawer, H S Oldenburg, et al.
Critical Care Medicine
|
July 1, 1997
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group
S M Opal, C J Fisher, J F Dhainaut, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 194) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 194 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 1997
Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia
T van der Poll, P M Jansen, W J Montegut, et al.
The Journal of Experimental Medicine
|
July 1, 1996
A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon
M B Welborn, K Van Zee, P D Edwards, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1996
Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081
K J Van Zee, L L Moldawer, H S Oldenburg, et al.
Critical Care Medicine
|
July 1, 1997
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group
S M Opal, C J Fisher, J F Dhainaut, et al.
Page
of 20